$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$81.60M
Market Cap
-
P/E Ratio
-0.72
EPS
$2.35
52 Week High
$0.27
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Equillium, Inc. is a clinical-stage biotechnology company based in La Jolla, California, specializing in the development of innovative therapeutics for severe autoimmune and inflammatory disorders where treatment options are limited. By leveraging its proprietary platform, Equillium targets specific immuno-inflammatory pathways, reinforcing its position as a leader in addressing complex diseases. The company is advancing a promising pipeline of clinical candidates designed to meet significant unmet medical needs, thus aiming to improve patient outcomes and create value within the biopharmaceutical industry.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
INTC
TLRY
AVGO
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
F
PLTD
AAL
HPE
KVUE
MARA
PLTR
VALE
BAC
RR
WULF
SNAP
CLSK
DNN
APLT
IREN
PFE
BYND
IRBT
GOOGL
NIO
CIFR
NFLX
ASBP
AMD
RKLB
GRAB
BITF
MTSR
FI
WBD
HOOD
JBLU
HL
QBTS
APLD
CAN
SOUN
CDE
T
AG
IVP
BTBT
NOK
SMR
EOSE
GOOG
LUV
TSM
BMY
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
INTC
TLRY
AVGO
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
F
PLTD
AAL
HPE
KVUE
MARA
PLTR
VALE
BAC
RR
WULF
SNAP
CLSK
DNN
APLT
IREN
PFE
BYND
IRBT
GOOGL
NIO
CIFR
NFLX
ASBP
AMD
RKLB
GRAB
BITF
MTSR
FI
WBD
HOOD
JBLU
HL
QBTS
APLD
CAN
SOUN
CDE
T
AG
IVP
BTBT
NOK
SMR
EOSE
GOOG
LUV
TSM
BMY